the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
Published 2 years ago • 231 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:48
the promise of fitusiran for the treatment of patients with hemophilia a and b
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
3:04
fitusiran significantly reduces bleeding events in patients with hemophilia a or b, with inhibitors
-
1:23
the safety and efficacy of eptacog beta in patients with hemophilia
-
3:29
fitusiran prophylaxis shows encouraging results in hemophilia patients
-
7:56
guy young: fitusiran for hemophilia a and b with inhibitors
-
1:15
the safety and efficacy of peritransplantation ruxolitinib in patients with mf
-
1:52
safety and efficacy of idasanutlin in pv
-
21:39
haemostasis and large blood transfusion
-
35:00
reverse hemophilia disability, gym diet guide, joint health muscle stretches, faq
-
10:01
2024年 flt3-itd基因突變急性血癌最新治療與成功經驗分享
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
0:39
promising therapeutic options emerging in hemophilia
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:23
association of cxcl13 and t follicular helper cells with hemophilia a inhibitor development
-
3:31
hemophilia a and b, new phase ii data confirming fitusiran and rna interference technology
-
4:48
an insight into the management of cytopenias in mf
-
1:11
long-term safety analysis of pirtobrutinib in r/r b-cell malignancies
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
2:14
risk-adapted treatment of et & pv
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp